Concepedia

Publication | Closed Access

INTRAVITREAL TUMOR NECROSIS FACTOR INHIBITORS IN THE TREATMENT OF REFRACTORY DIABETIC MACULAR EDEMA

DOI

93

Citations

21

References

2010

Year

Lihteh Wu, Erick Hernández-Bogantes, José A. Roca, J. Fernando Arévalo, Karen Barraza, Andrés F. Lasave
Retina

Abstract

Both intravitreal adalimumab and infliximab do not appear to benefit eyes with refractory diabetic macular edema. Intravitreal injections of infliximab may elicit a severe intraocular inflammatory reaction.

References

YearCitations

Page 1